Surya N. Mohapatra, Ph.D.
Dr. Mohapatra has held senior leadership positions in the health care industry for more than 35 years, most recently as the Chairman, President and Chief Executive Officer of Quest Diagnostics, Incorporated—the world’s leading provider of diagnostic testing, information, and services—where he had been a senior executive from 1999 to 2012. Prior to joining Quest Diagnostics, he served as Senior Vice President and a member of the Executive Committee of Picker International (now part of Philips Medical Systems), where he played an important role in the design, manufacture, and commercialization of magnetic resonance imaging (MRI) technology during his tenure.
In addition to his current membership on the Board of Directors of Xylem Inc. (a leading global water technology and transport company) and Leidos Inc. (a science and technology solutions leader in the defense, intelligence, homeland security, civil, and healthcare sectors), Dr. Mohapatra is active in a number of not-for-profit institutions. He is a trustee of the Rockefeller University, and an Executive in Residence at the Columbia Business School. He is also a Board member of Malaria No More, a nonprofit organization that aims to end deaths caused by Malaria.
Dr. Mohapatra holds a Bachelor of Science in Electrical Engineering from the National Institute of Technology, Rourkela, India; a Master of Science in Medical Electronics from the University of Salford, England; and a Doctorate in Medical Physics from the University of London and the Royal College of Surgeons of England. He is the author of several publications and patents, including the book Noninvasive Cardiovascular Monitoring by Electrical Impedance Technique.